Cite
MLA Citation
Francesca Lombardi et al.. “Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting.” HIV research & clinical practice, vol. 23, no. 1, 2022, pp. 28–36. http://access.bl.uk/ark:/81055/vdc_100158019244.0x000002